HST vs RPRX · P/E 16, rev $6.11B vs P/E 15, rev $1.30B
Host Hotels & Resorts Inc (HST) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Host Hotels & Resorts Inc (HST) is a reit - hotel & motel company listed on US.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported HST revenue for 2025-12-31 was $6.11B. Net income was $765.0M. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. HST currently screens at market cap $15.94B and trailing P/E 15.6.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
HST currently screens at market cap $15.94B and trailing P/E 15.6. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the HST and RPRX stock pages for the full models.
Not investment advice.